Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Changjiang Sunshine Pharmaceutical is a Chinese pharmaceutical company and a key subsidiary of Yi Chang HEC Sunshine Pharmaceutical (HEC Pharm). Located in the Changjiang Li Autonomous County of Hainan, the company serves as a major manufacturing and production base for the group's core products. Its portfolio is heavily focused on anti-viral medications, most notably the production of Oseltamivir (Kewei), alongside treatments for endocrine and cardiovascular diseases. The facility is equipped for large-scale production of active pharmaceutical ingredients (APIs) and finished dosage forms, supporting HEC Pharm's dominant position in the Chinese influenza market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Changjiang Sunshine Pharmaceutical.